R&D Pipeline Products Poised to Deliver Yield Benefits and Value to Farmers
LONDON, Sept. 11 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) sees a significant growth opportunity in continuing to create more yield for farmers worldwide through its investment in plant biotechnology and breeding, leading to more than doubling the company's 2007's gross profit in 2012, Steve Padgette, Monsanto's vice president of biotechnology, will tell investors. Padgette will deliver his remarks as part of the UBS Best of Americas Conference on Friday in London. The opportunity for Monsanto is global and exists not just with the technologies in hand, but with what is yet to come in its R&D pipeline, Padgette will state.
"After more than 10 years of farmers planting biotech traits, the prospects for growth are substantial," Padgette said. "The opportunity for existing biotech traits outside the United States is nearly 275 million acres and a little more than a third of those acres carry Monsanto's trait technology currently."
The opportunity for international growth is most imminent and substantial in Brazil and Argentina where Monsanto is launching new trait packages. In Argentina, Monsanto has received approval for a double-stack trait combination, YieldGard(R) Corn Borer with Roundup Ready(R) Corn 2, and plans to offer the combination on more than 1 million acres in its first year of introduction. In Brazil, Monsanto received planting approval for the YieldGard Corn Borer trait and is planning for a 1 million to 2 million acre launch for the upcoming 2008-2009 season.
Padgette will also discuss the progress and momentum behind a number of projects in Monsanto's R&D pipeline, highlighting key soybean and corn projects.<
|SOURCE Monsanto Company|
Copyright©2008 PR Newswire.
All rights reserved